Gene Therapy Restores Hearing in Children with OTOF-Related Congenital Deafness: NEJM Dr. Shravani Dali29 Oct 2025 9:00 PM ISTA recent phase I/II CHORD trial published in the New England Journal of Medicine has shown that a novel gene therapy targeting OTOF variants can...
Telitacicept Improves Clinical Response but Increases Infection Risk in Active SLE: NEJM Dr. Shravani Dali28 Oct 2025 8:30 PM ISTIn a 52-week trial of patients with active systemic lupus erythematosus (SLE) receiving standard background therapy, telitacicept produced a higher...
Drug combo cuts risk of death in advanced prostate cancer by 40%: NEJM Dr. Kamal Kant Kohli27 Oct 2025 10:00 PM ISTMen whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the...
Low-Dose Aspirin Cuts Recurrence Risk in PI3K-Altered Colorectal Cancer, Trial Shows Medha Baranwal21 Oct 2025 9:30 PM ISTSweden: A new randomized trial has found that daily low-dose aspirin significantly lowers the risk of colorectal cancer recurrence in patients whose...
Do CT scans increase childhood cancer risk? A UF researcher has the answer Dr. Kamal Kant Kohli27 Sept 2025 7:30 AM ISTA recent study links exposure to radiation from medical imaging to a small-but-significant risk of blood cancers among children and adolescents. But...
Permethrin-treated Baby Wraps Cut Malaria Risk in Children: NEJM Medha Baranwal26 Sept 2025 8:45 AM ISTUSA: A randomized trial conducted in Uganda has shown that permethrin-treated baby wraps reduced malaria incidence by 66% in young children before...
Shunting Benefits in Idiopathic Normal-Pressure Hydrocephalus: NEJM Jacinthlyn Sylvia21 Sept 2025 9:00 PM ISTA new clinical trial published in the New England Journal of Medicine found that among patients with idiopathic normal-pressure hydrocephalus...
Dual antiplatelet therapy not more effective than aspirin alone after CABG: Study Dr. Kamal Kant Kohli15 Sept 2025 8:30 AM ISTDual antiplatelet therapy (DAPT) was not more effective than aspirin alone for the prevention of major adverse cardiovascular events and increased...
Aficamten superior to metoprolol for symptomatic obstructive hypertrophic cardiomyopathy: ESC Study Dr. Kamal Kant Kohli10 Sept 2025 8:45 AM ISTAficamten treatment was associated with significant improvements in exercise capacity and symptoms compared with metoprolol in patients with...
Worse outcomes with aspirin in high-risk chronic coronary syndrome patients who require long-term anticoagulation: ESC Study Dr. Kamal Kant Kohli9 Sept 2025 11:45 AM ISTAdding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary syndrome (CCS) who...
Post MI Beta blockers may offer no benefit for heart attack patients and women can have worse outcomes: ESC Study Dr. Kamal Kant Kohli7 Sept 2025 8:45 PM ISTBeta blockers-drugs commonly prescribed for a range of cardiac conditions, including heart attacks-provide no clinical benefit for patients who have...
